Urinary biomarker discovery in gliomas using mass spectrometry-based clinical proteomics
Abstract Background Gliomas are the most common primary malignant brain tumors and have a poor prognosis. Early detection of gliomas is crucial to improve patient outcomes. Urine accumulates systematic body changes and thus serves as an excellent early biomarker source. Methods At the biomarker disc...
Main Authors: | Jianqiang Wu, Jun Zhang, Jing Wei, Yuanli Zhao, Youhe Gao |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-04-01
|
Series: | Chinese Neurosurgical Journal |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s41016-020-00190-5 |
Similar Items
-
Urinary Biomarkers of Brain Diseases
by: Manxia An, et al.
Published: (2015-12-01) -
Early urinary candidate biomarkers and clinical outcomes of intervention in a rat model of experimental autoimmune encephalomyelitis
by: Mindi Zhao, et al.
Published: (2023-08-01) -
Dynamic urinary proteomic analysis in a Walker 256 intracerebral tumor model
by: Linpei Zhang, et al.
Published: (2019-07-01) -
Urine Proteomics in the Era of Mass Spectrometry
by: Ashley Beasley-Green
Published: (2016-11-01) -
Label-Free Liquid Chromatography–Mass Spectrometry Proteomic Analysis of the Urinary Proteome for Measuring the Escitalopram Treatment Response From Major Depressive Disorder
by: Yuhang Huan, et al.
Published: (2021-09-01)